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journal homepage: http: / /www.kjms-onl ine.comLETTER TO THE EDITORHypernatremia-associated coma caused by
glucocorticoid replacement for adrenal crisis in
an unrecognized central diabetes insipidus
patientTo the Editor,
Intracranial germinoma is a rare disease primarily involving
midline structures in the brain, with central diabetes insip-
idus (DI) being the most common presentation. Few cases of
intracranial germinoma presenting with adrenal crisis have
been reported in the literature. We herein report a unique
case of hypernatremic coma after glucocorticoid replace-
ment for adrenal crisis in an unrecognized central DI.
An 18-year-old male had a history of dysthymic disorder.
He presented to our emergency department with com-
plaints of weakness, nausea, poor appetite, and inter-
mittent fever. He had a body mass index 15.4 kg/m2. His
vital signs included a blood pressure (BP) of 68/40 mmHg,
a pulse rate of 137/min, a respiratory rate of 18/min, and
a body temperature of 39.2C. Septic shock was suspected.
Fluid replacement with 0.9% sodium chloride (NaCl), anti-
biotics, and vasopressors was administered. Results of his
blood cell analysis revealed the following measurements:
a white blood cell count of 8900/mm3, a C-reactive protein
level of 3.5 mg/L, a serum sodium level of 145.6 mEq/L,
a cortisol level of 4.5 mg/dL (5e17.9 mg/dL), and an adre-
nocorticotropin level of 5 pg/mL (<46 pg/mL). Hydrocor-
tisone was prescribed for suspected adrenal crisis and the
patient’s vital signs improved. The patient underwent
a brain magnetic resonance imaging (MRI), which revealed
three heterogeneous masses in the suprasellar area, lateral
ventricle, and pineal gland (Fig. 1). The pituitary hormone
levels, as well as plasma and urine osmolality levels were
sent for laboratory analysis, but the laboratory data were
unavailable while the patient was sent to the regular ward.
The patient’s level of consciousness deteriorated to
E2V1M4 by the next morning. His vital signs included a BP of
110/66 mmHg and a pulse rate of 62/minute. Emergency
blood biochemical analysis revealed a serum sodium level of1607-551X/$36 Copyright ª 2013, Kaohsiung Medical University. Publish
http://dx.doi.org/10.1016/j.kjms.2013.01.009184.2mEq/L, a urine osmolality of 126mOsm/kg, anda urine-
specific gravity <1.005. Central DI was suspected and vaso-
pressin (Pitressin) and Suntose (Dextrose 50mg/mLþ Sodium
Chloride 4.5 mg/mL) were intravenously administered. The
patient’s urine osmolality increased to 488 mOsm/kg and his
urine-specific gravity increased to 1.015. The hypernatremia
gradually resolved and the patient regained consciousness
(E4V5M6) 2 days later. He then underwent a brain tumor bi-
opsy and a pathological analysis of the tumor revealed ger-
minoma. His pituitary hormone level analysis revealed
a thyroid-stimulating hormone level of 0.93 mIU/mL
(0.25e4.0 mIU/mL), a free T4 level of 0.59 ng/dL
(0.68e1.4 ng/dL), a luteinizing hormone level <0.2 mIU/mL
(1.24e8.6 mIU/mL), a follicle-stimulating hormone level of
0.2 mIU/mL (1.27e19 mIU/mL), a testosterone level of
0.1 ng/mL (1.75e7.81 ng/mL), and an insulin-like growth
factor 1 level of 78 ng/mL (163e584 ng/mL). The patient
received 4500 cGy of radiotherapy. Cortisone acetate, levo-
thyroxine sodium (Eltroxin), testoviron depot Sustanon, and
desmopressin acetate nasal spray were prescribed on dis-
charge and the patient was followed on an outpatient basis.
The most commonly reported manifestation of intra-
cranial germinoma is central DI [1,2]. Central DI can also
mimic other neurological problems including gait dis-
turbance, symptoms of cranial nerve involvement, or hor-
mone deficiency [3,4]. Although intracranial germinoma
may cause hypothalamic/pituitary dysfunction, adrenal
crisis as the first presentation is rare. Hyponatremia is
frequently detected in adrenal insufficiency. In our case,
the initial serum sodium level was within normal range.
After the standard treatment for adrenal crisis, hyper-
natremic coma occurred. Possible explanations for this
phenomenon include hypocortisolism that can increase
arginine vasopressin (AVP) secretion and impair renal
output resulting in hyponatremia [5]. Central DIed by Elsevier Taiwan LLC. All rights reserved.
Figure 1. Heterogeneous nodules in the suprasellar area,
lateral ventricle, and pineal gland area.
520 Letter to the Editorcounterbalances this effect and contributes to normona-
tremia. Glucocorticoids administered for adrenal crisis
might suppress AVP leading to DI. Physiological saline in-
fusions may have been another precipitating factor to the
hypernatremia. In addition, shock status may also cause
poor renal perfusion and indirectly mask polyuria in DI.
Close clinical follow-up including electrolytes and fluid
status is recommended if adrenal crisis combined with
central DI is suspected. Because germinoma is very radio-
sensitive, it can be successfully treated with radiation
therapy. Hormone replacement therapy and further evalu-
ation with follow-up brain MRI and tumor markers are rec-
ommended for long-term care.References
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